{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:27:09Z","timestamp":1762421229113,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002160","name":"Jain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtm.2019.10.002","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T20:32:04Z","timestamp":1571085124000},"page":"294-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy"],"prefix":"10.1016","volume":"15","author":[{"given":"Tuhin K.","family":"Guha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pichavant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele P.","family":"Calos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.10.002_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(12)61897-2","article-title":"Muscular dystrophies","volume":"381","author":"Mercuri","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2019.10.002_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","article-title":"The pathogenesis and therapy of muscular dystrophies","volume":"16","author":"Guiraud","year":"2015","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.omtm.2019.10.002_bib3","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/hmg\/ddh153","article-title":"Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in\u00a0vivo and in\u00a0vitro","volume":"13","author":"Kramerova","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.10.002_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(95)90368-2","article-title":"Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A","volume":"81","author":"Richard","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2019.10.002_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/1682","article-title":"Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy","volume":"20","author":"Liu","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2019.10.002_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/1689","article-title":"A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B","volume":"20","author":"Bashir","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2019.10.002_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature01573","article-title":"Defective membrane repair in dysferlin-deficient muscular dystrophy","volume":"423","author":"Bansal","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2019.10.002_bib8","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/hmg\/ddh212","article-title":"Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency","volume":"13","author":"Ho","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.10.002_bib9","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1083\/jcb.142.6.1461","article-title":"Progressive muscular dystrophy in \u03b1-sarcoglycan-deficient mice","volume":"142","author":"Duclos","year":"1998","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2019.10.002_bib10","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/hmg\/ddq065","article-title":"Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer","volume":"19","author":"Lostal","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.10.002_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nm1439","article-title":"rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice","volume":"12","author":"Gregorevic","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2019.10.002_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ymthe.2005.09.017","article-title":"Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A","volume":"13","author":"Bartoli","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCULATIONAHA.113.001340","article-title":"Restriction of calpain3 expression to the skeletal muscle prevents cardiac toxicity and corrects pathology in a murine model of limb-girdle muscular dystrophy","volume":"128","author":"Roudaut","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.omtm.2019.10.002_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/acn3.172","article-title":"AAV.dysferlin overlap vectors restore function in dysferlinopathy animal models","volume":"2","author":"Sondergaard","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.omtm.2019.10.002_bib15","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.ymthe.2017.05.013","article-title":"Structure-based designed nano-dysferlin significantly improves dysferlinopathy in BLA\/J mice","volume":"25","author":"Llanga","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.mt.6300022","article-title":"Phenotypic correction of \u03b1-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector","volume":"15","author":"Fougerousse","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ana.21732","article-title":"Limb-girdle muscular dystrophy type 2D gene therapy restores \u03b1-sarcoglycan and associated proteins","volume":"66","author":"Mendell","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2019.10.002_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/hgtb.2012.243","article-title":"Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy","volume":"24","author":"Louis Jeune","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2019.10.002_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/hgtb.2018.038","article-title":"Assessment of humoral, innate, and T-cell immune responses to adeno-associated virus vectors","volume":"29","author":"Calcedo","year":"2018","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2019.10.002_bib21","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib22","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in\u00a0vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.omtm.2019.10.002_bib23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ymthe.2004.05.004","article-title":"A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs","volume":"10","author":"Hagstrom","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/hum.2009.133","article-title":"Functional efficacy of dystrophin expression from plasmids delivered to mdx mice by hydrodynamic limb vein injection","volume":"21","author":"Zhang","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/hum.2009.172","article-title":"Evaluation of hydrodynamic limb vein injections in nonhuman primates","volume":"21","author":"Hegge","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/hum.2010.160","article-title":"Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA","volume":"22","author":"Wooddell","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.omtm.2017.10.005","article-title":"DNA-mediated gene therapy in a mouse model of limb girdle muscular dystrophy 2B","volume":"7","author":"Ma","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2019.10.002_bib28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/mt.2011.137","article-title":"Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy","volume":"20","author":"Fan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1089\/hum.2015.023","article-title":"High-pressure transvenous perfusion of the upper extremity in human muscular dystrophy: A safety study with 0.9% saline","volume":"26","author":"Fan","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0764-4469(99)80003-1","article-title":"Long-term, high level in\u00a0vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle","volume":"321","author":"Mir","year":"1998","journal-title":"C.\u00a0R. Acad. Sci. III"},{"key":"10.1016\/j.omtm.2019.10.002_bib31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nbt0998-867","article-title":"Gene transfer into muscle by electroporation in\u00a0vivo","volume":"16","author":"Aihara","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2019.10.002_bib32","series-title":"Gene Vaccines, Chapter 8","first-page":"163","article-title":"Electroporation based TriGrid\u2122 delivery system (TDS) for DNA vaccine administration","author":"Hannaman","year":"2012"},{"key":"10.1016\/j.omtm.2019.10.002_bib33","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.10.002_bib34","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1371\/journal.pone.0000789","article-title":"Quadrupling muscle mass in mice by targeting TGF-\u03b2 signaling pathways","volume":"2","author":"Lee","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.10.002_bib35","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1093\/hmg\/ddt342","article-title":"Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model","volume":"22","author":"Rodino-Klapac","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.10.002_bib36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/mt.2014.200","article-title":"A phase 1\/2a follistatin gene therapy trial for becker muscular dystrophy","volume":"23","author":"Mendell","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/9780470942390.mo110141","article-title":"Myofiber damage evaluation by Evans blue dye injection","volume":"1","author":"Wooddell","year":"2011","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.omtm.2019.10.002_bib38","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1172\/JCI68458","article-title":"Assessment of disease activity in muscular dystrophies by noninvasive imaging","volume":"123","author":"Maguire","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2019.10.002_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.2008.03753.x","article-title":"Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment","volume":"154","author":"Pearson","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.omtm.2019.10.002_bib40","article-title":"Three novel immune-deficient mouse models of muscular dystrophy","volume":"1","author":"Pichavant","year":"2017","journal-title":"PLoS Curr. Musc. Dyst."},{"key":"10.1016\/j.omtm.2019.10.002_bib41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1073\/pnas.0504505102","article-title":"Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration","volume":"103","author":"Bertoni","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.10.002_bib42","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1093\/hmg\/ddv288","article-title":"Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy","volume":"24","author":"Lee","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.10.002_bib43","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.gt.3302928","article-title":"AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency","volume":"14","author":"Bartoli","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/cpt.542","article-title":"Genome editing techniques and their therapeutic applications","volume":"101","author":"Calos","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib45","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1056\/NEJMcibr1601383","article-title":"The CRISPR way to think about Duchenne\u2019s","volume":"374","author":"Calos","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2019.10.002_bib46","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/mt.2015.192","article-title":"CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice","volume":"24","author":"Xu","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.002_bib47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mt.2016.40","article-title":"Precise correction of disease mutations in induced pluripotent stem cells derived from patients with limb girdle muscular dystrophy","volume":"24","author":"Turan","year":"2016","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905011930110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905011930110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:22:38Z","timestamp":1762420958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905011930110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":47,"alternative-id":["S232905011930110X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.10.002","relation":{},"ISSN":["2329-0501"],"issn-type":[{"type":"print","value":"2329-0501"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}